摘要
目的:分析在慢性盆腔炎患者的治疗中应用中药红藤方保留灌肠联合常规西药治疗的效果。方法:将96例慢性盆腔炎患者随机分为对照组和观察组,每组48例。对照组应用常规西药治疗,观察组在对照组基础上应用中药红藤方保留灌肠。比较两组治疗前后的血清炎症因子水平、血液流变学指标及症状积分变化,并对比两组的治疗效果。结果:治疗后两组的血清肿瘤坏死因子(Tumor Necrosis Factor,TNF-α)、白细胞介素-1(Interleukin-1,IL-1)、全血高切粘度、全血低切粘度、红细胞压积、纤维蛋白原水平、症状积分均下降(P<0.05),观察组低于对照组(P<0.05);观察组的治疗有效率高于对照组(P<0.05)。结论:在慢性盆腔炎患者的治疗中应用中药红藤方灌肠联合常规西药可更好地降低炎症因子水平、改善血液流变学、促进症状的好转,并可提高治疗效果。
Objective:To analyze efficacy of the Hongteng prescription(红藤方)enema plus conventional western medicine on chronic pelvic inflammatory disease.Methods:96 patients with chronic pelvic inflammatory disease were randomly divided into the control group and the observation group,48 cases in each group.The control group was treated with conventional western medicine,while the observation group was treated with the Hongteng prescription enema more.The levels of serum inflammatory factors,hemorheological indexes and symptom scores before and after treatment and efficiency between the two groups were compared.Results:After treatment,the levels of serum TNF-α,IL-1,whole blood high-viscosity,whole blood low-cut viscosity,hematocrit,fibrinogen level and symptom scores in groups were decreased(P<0.05),those in the observation group were lower than the control group(P<0.05).The efficiency in the observation group was higher than the control group(P<0.05).Conclusion:The application of the Hongteng prescription enema plus conventional western medicine on chronic pelvic inflammatory disease can better reduce the level of inflammatory factors,improve hemorheology,promote the improvement of symptoms and improve the therapeutic effect.
出处
《中医临床研究》
2019年第29期99-101,共3页
Clinical Journal Of Chinese Medicine
关键词
慢性盆腔炎
红藤方
西药
血液流变学
Chronic pelvic inflammatory disease
The Hongteng prescription
Western medicine
Hemorheology